Utah Medical Products (UTMD) Market Capitalization (2010 - 2026)

Utah Medical Products has reported Market Capitalization for 17 years, with the latest figure at $219.6 million in Q2 2026.

• On a quarterly basis, Market Capitalization rose 19.94% year-over-year to $219.6 million in Q2 2026; TTM through Jun 2026 was $219.6 million, a 19.94% increase from a year earlier, with the FY2025 full-year figure at $178.3 million, down 13.03% from the prior year.
• Market Capitalization was $219.6 million for Q2 2026 at Utah Medical Products, up from $197.4 million in the prior quarter.
• The five-year high for Market Capitalization was $364.7 million in Q4 2022, with the low at $178.3 million in Q4 2025.
• Average Market Capitalization over 5 years is $261.2 million, with a median of $244.5 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2026: Market Capitalization plunged 32.91% in 2024, then rose 19.94% in 2026.
• Over 5 years, Market Capitalization stood at $364.7 million in 2022, then dropped by 16.22% to $305.6 million in 2023, then slumped by 32.91% to $205.0 million in 2024, then decreased by 13.03% to $178.3 million in 2025, then gained by 23.15% to $219.6 million in 2026.
• The last three Market Capitalization figures came in at $219.6 million (Q2 2026), $197.4 million (Q1 2026), and $178.3 million (Q4 2025), per Business Quant data.